Consider the individual when interpreting QOL effects of treatments Newsletter Article 11 February 2013 Pages: 2 - 2
Second edition of the guidelines for economic evaluation of pharmaceuticals Newsletter Article 11 February 2013 Pages: 3 - 3
Some informal comments on the updated Canadian economic guidelines Newsletter Article 11 February 2013 Pages: 5 - 7
Zidovudine alone vs triple therapy in advanced HIV infection Newsletter Article 11 February 2013 Pages: 7 - 7
Physicians miss opportunities to aid smoking cessation Newsletter Article 11 February 2013 Pages: 8 - 8
Budesonide CIR capsules cost effective in Crohn’s disease Newsletter Article 11 February 2013 Pages: 8 - 8
Antimicrobial prescribing improved at a Dutch hospital Newsletter Article 11 February 2013 Pages: 9 - 9
Comparing the costs of treatment for uncomplicated GORD Newsletter Article 11 February 2013 Pages: 9 - 9
Does aggressive antihypertensive therapy improve patient QOL? Newsletter Article 11 February 2013 Pages: 10 - 10
Community pharmacists’ attitudes towards QOL assessment Newsletter Article 11 February 2013 Pages: 10 - 10
Cost-containment initiatives proposed by Spanish government Newsletter Article 11 February 2013 Pages: 11 - 11